Literature DB >> 16736499

IGH switch breakpoints in Burkitt lymphoma: exclusive involvement of noncanonical class switch recombination.

Jeroen E J Guikema1, Conny de Boer, Eugenia Haralambieva, Laura A Smit, Carel J M van Noesel, Ed Schuuring, Philip M Kluin.   

Abstract

Most chromosomal t(8;14) translocations in sporadic Burkitt lymphomas (BL) are mediated by immunoglobulin class switch recombination (CSR), yet all tumors express IgM, suggesting an incomplete or exclusively monoallelic CSR event. We studied the exact configuration of both the nontranslocated IGH allele and the MYC/IGH breakpoint by applying a combination of low- and high-resolution methods (interphase FISH, DNA fiber FISH, long-distance PCR, and Southern blotting) on 16 BL. IGH class switch events involving the nontranslocated IGH allele were not observed. Thirteen cases had MYC/IGH breakpoints in or nearby IGH switch (S) sites, including five at Smu, three at Sgamma and five at Salpha. All eight translocations with a breakpoint at Sgamma or Salpha were perfectly reciprocal, without deletion of Cmu-Cdelta or other CH elements. Internal Smu deletions claimed to be a marker for CSR activity and implicated in stabilization of IgM expression were found in BL but did not correlate with downstream translocation events. This study shows that switch breakpoints in sporadic BL are exclusively resolved by a noncanonical recombination mechanism involving only one switch region. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16736499     DOI: 10.1002/gcc.20345

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  5 in total

Review 1.  Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.

Authors:  Arantza Onaindia; L Jeffrey Medeiros; Keyur P Patel
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

2.  MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas.

Authors:  Gabriella Aquino; Laura Marra; Monica Cantile; Annarosaria De Chiara; Giuseppina Liguori; Maria Pia Curcio; Rocco Sabatino; Giuseppe Pannone; Antonio Pinto; Gerardo Botti; Renato Franco
Journal:  Infect Agent Cancer       Date:  2013-09-30       Impact factor: 2.965

Review 3.  Paradoxical role of Id proteins in regulating tumorigenic potential of lymphoid cells.

Authors:  Sumedha Roy; Yuan Zhuang
Journal:  Front Med       Date:  2018-07-24       Impact factor: 4.592

4.  Grey zone lymphomas: lymphomas with intermediate features.

Authors:  Sylvia Hoeller; Christiane Copie-Bergman
Journal:  Adv Hematol       Date:  2012-04-03

Review 5.  Epstein-Barr virus and Burkitt lymphoma.

Authors:  Martin Rowe; Leah Fitzsimmons; Andrew I Bell
Journal:  Chin J Cancer       Date:  2014-11-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.